RU95116449A - APPLICATION OF RILUZOLE AS A RADIO-REDUCER AND METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION - Google Patents

APPLICATION OF RILUZOLE AS A RADIO-REDUCER AND METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION

Info

Publication number
RU95116449A
RU95116449A RU95116449/14A RU95116449A RU95116449A RU 95116449 A RU95116449 A RU 95116449A RU 95116449/14 A RU95116449/14 A RU 95116449/14A RU 95116449 A RU95116449 A RU 95116449A RU 95116449 A RU95116449 A RU 95116449A
Authority
RU
Russia
Prior art keywords
riluzole
radio
pharmaceutical composition
reducer
producing
Prior art date
Application number
RU95116449/14A
Other languages
Russian (ru)
Other versions
RU2142801C1 (en
Inventor
Прэт Жереми
Стюсман Жан-Мари
Original Assignee
Рон-Пуленк Роре С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9300073A external-priority patent/FR2700116B1/en
Application filed by Рон-Пуленк Роре С.А. filed Critical Рон-Пуленк Роре С.А.
Publication of RU95116449A publication Critical patent/RU95116449A/en
Application granted granted Critical
Publication of RU2142801C1 publication Critical patent/RU2142801C1/en

Links

Claims (4)

1. Применение рилузола или фармацевтически приемлемых солей этого соединения в качестве агента - радиовосстановителя.1. The use of riluzole or pharmaceutically acceptable salts of this compound as a radio-reducing agent. 2. Применение по п.1, в котором агент вводят оральным путем в виде средства, содержащего 25-200 мг рилузола. 2. The use according to claim 1, in which the agent is administered orally in the form of an agent containing 25-200 mg of riluzole. 3. Применение по п.1, в котором агент вводят внутривенным путем в виде средства, содержащего 12,5 - 200 мг рилузола. 3. The use according to claim 1, in which the agent is administered intravenously in the form of an agent containing 12.5 to 200 mg of riluzole. 4. Способ получения фармкомпозиции, обладающей радиовосстановительными свойствами, отличающийся тем, что смешивают рилузол или фармацевтически приемлемые соли этого соединения с одним или несколькими разбавителями и/или совместимыми и фармацевтически приемлемыми вспомогательными веществами. 4. A method of obtaining a pharmaceutical composition having radio-reducing properties, characterized in that riluzole or pharmaceutically acceptable salts of this compound are mixed with one or more diluents and / or compatible and pharmaceutically acceptable excipients.
RU95116449A 1993-01-07 1994-01-03 Agent for radioprotection after irradiation and method of preparing composition showing radioprotective property RU2142801C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR93/00073 1993-01-07
FR9300073A FR2700116B1 (en) 1993-01-07 1993-01-07 Application of anti-convulsants as radioprotective agents.
PCT/FR1994/000002 WO1994015600A1 (en) 1993-01-07 1994-01-03 Application of riluzole as a radiorestorer

Publications (2)

Publication Number Publication Date
RU95116449A true RU95116449A (en) 1998-01-10
RU2142801C1 RU2142801C1 (en) 1999-12-20

Family

ID=9442861

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95116449A RU2142801C1 (en) 1993-01-07 1994-01-03 Agent for radioprotection after irradiation and method of preparing composition showing radioprotective property

Country Status (22)

Country Link
US (1) US5656647A (en)
EP (1) EP0678022B1 (en)
JP (1) JP3262275B2 (en)
KR (1) KR100298806B1 (en)
AT (1) ATE145135T1 (en)
AU (1) AU675281B2 (en)
CA (1) CA2152280C (en)
CZ (1) CZ284327B6 (en)
DE (1) DE69400908T2 (en)
DK (1) DK0678022T3 (en)
ES (1) ES2093515T3 (en)
FR (1) FR2700116B1 (en)
GR (1) GR3021604T3 (en)
HU (1) HU217131B (en)
IL (1) IL108283A (en)
MX (1) MX9400288A (en)
NO (1) NO307204B1 (en)
PL (1) PL309593A1 (en)
RU (1) RU2142801C1 (en)
SK (1) SK279777B6 (en)
WO (1) WO1994015600A1 (en)
ZA (1) ZA9427B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787028B1 (en) 1998-12-15 2002-10-18 Aventis Pharma Sa USE OF RILUZOLE IN THE TREATMENT OF ACOUSTIC TRAUMA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (en) * 1980-10-17 1982-04-23 Pharmindustrie NEW AMINO-2 TRIFLUOROMETHOXY-6 BENZOTHIAZOLE-BASED MEDICINAL PRODUCT
SU1109392A1 (en) * 1983-03-01 1984-08-23 Ордена Трудового Красного Знамени Институт Химии И Химической Технологии Ан Литсср Process for preparing aromatic thiopropanesulfonic acids or their salts
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
US4918090A (en) * 1988-01-25 1990-04-17 Warner-Lambert Company Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
FR2662160B1 (en) * 1990-05-18 1992-07-24 Rhone Poulenc Sante ALKYLTHIO-3 PROPYL-3 BENZOTHIAZOLINE DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
US5240948A (en) * 1989-12-13 1993-08-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. 3-(3-alkylthiopropyl)benzothiazoline derivatives, their preparation and the medicament containing them

Similar Documents

Publication Publication Date Title
CA2004239A1 (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
RU95114405A (en) USE OF RILUZOL AS A MEDICINAL PRODUCT FOR TREATMENT OF NEUROLOGICAL DISORDERS CAUSED BY INJURIES AND METHOD FOR PRODUCING A MEDICINE
LU91223I2 (en) Ivabradine and its pharmaceutically acceptable derivatives (procoralan)
RU93004970A (en) Derivatives of cycloalkyl-substituted glutaramide, their use, pharmaceutical composition
SE9503143D0 (en) New preparation
EP1428821A8 (en) Piperidin-4-yl amines with analgesic effect
KR960700054A (en) APPLICATION OF RILUZOLE IN THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES
CA2194885A1 (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
BR9809571A (en) Medicinal composition and process to produce it
IL158155A (en) Use of erythropoietin for the preparation of a medicament to ameliorate chemotherapy-induced toxicity
KR890003379A (en) Doxazosin as an anti-atherosclerotic agent
RU2000122435A (en) INDOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM
ES2116612T3 (en) NEW BIS-NAFTALIMIDES FOR THE TREATMENT OF CANCER.
KR920017669A (en) Gallium compounds
RU95116449A (en) APPLICATION OF RILUZOLE AS A RADIO-REDUCER AND METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
WO1991018606A3 (en) Orally active nonaddicting analgesics
ATE118759T1 (en) ETHANOLAMINE BENZOATE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.
GB8820654D0 (en) Pharmaceutical compositions
KR930002322A (en) Pyrazole derivatives
CA2030344A1 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
ZA897505B (en) Stable oxapenem-3-carboxylic acids and their use as beta-lactamase inhibitors
KR960003728A (en) How to Reduce Lung Capillary Leak in Mammals
ES2117114T3 (en) NEW DERIVATIVES OF TIAXOLIDIN-DIONA, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
SE8402199L (en) PHARMACEUTICAL PREPARATION CONTAINING CO-DERGOCRIN AND A CALCIUM ANTAGONIST